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Summary Noninfectious or unusual infectious diseases may present with clinical,
radiological and laboratorial characteristics of community-acquired pneumonia
(CAP). Usually their presence is only suspected after treatment failure, leading to
inappropriate interventions, unnecessary costs and risks related to the untreated
potentially life-threatening disease. The present study aimed to assess the
noninfectious or unusual infectious diseases that may be misdiagnosed as CAP that
progresses with treatment failure.
Sixteen hospitalized patients with presumptive diagnosis of CAP and treatment
failure were described. The most prevalent symptoms were fever and cough.
Radiological pattern of air-space disease was observed in 10 (62%) patients. The
diagnosis was established by autopsy (12%) or invasive procedures (88%), as follows:
open lung biopsy (nine), flexible fiberoptic bronchoscopy (two), transthoracic fine
needle aspiration (two) and bone marrow aspiration (one). Eight patients had
noninfectious diseases: pulmonary embolism, cryptogenic organizing pneumonia,
Wegener’s granulomatosis, hypersensitivity pneumonitis, bronchocentric granulo-
matosis, neoplastic disease and acute leukemia. The unusual infectious diseases
were: tuberculosis, cryptococcosis, actinomycosis, histoplasmosis and paracocci-
dioidomycosis.
Patients with noninfectious or unusual infectious diseases may present with
symptoms and radiological findings that mimic CAP. These diseases should always be
suspected in patients who do not respond to initial empirical antimicrobial
treatment, especially young patients or those without comorbidity.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
The delay in resolution of community-acquired
pneumonia (CAP) is a common clinical problem.
Failure to improve after antimicrobial treatment is
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age, comorbidity, resistant pathogens, complica-
tion of pneumonic process or inadequate antimi-
crobial selection.1,2 However, some noninfectious
or unusual infectious diseases may present with a
similar clinical, radiological and laboratorial char-
acteristics of CAP.2 This may represent a diagnostic
challenge to the physician, especially because
diseases that mimic CAP usually are only considered
in the differential diagnosis after treatment fail-
ure. Misdiagnosis then leads to excessive and/or
inappropriate interventions, unnecessary costs,
and the respective risks related to the untreated
potentially life-threatening disease. Due to low
prevalence of these disorders, compared to the
high prevalence of CAP, the diagnosis is often
achieved lately and by invasive procedures. The
delayed diagnosis results in several unnecessary
courses of antibiotic treatment and, probably,
higher rates of morbidity and mortality.
We hypothesized that patients with clinical
diagnosis of community-acquired pneumonia who
fail to improve after the institution of antibiotics
and in whom physicians fail to achieve the initial
etiological diagnosis should be screened to the
presence of unusual diseases that may be mimick-
ing pneumonia. The present study aimed to assess
the noninfectious or unusual infectious diseases
that may be misdiagnosed as CAP that progresses
with treatment failure.
Methods
A prospective study was conducted between 1994
and 2000 in a 400-bed, tertiary-care, university
teaching hospital in Brazil. All consecutive hospi-
talized patients with suspicion of CAP were
evaluated. The diagnosis of pneumonia was based
on the detection of a new, persistent pulmonary
infiltrate compatible with pneumonia and at least
two of the following clinical criteria: (1) fever or
hypothermia (temperature4381C oro35.51C); (2)
leukopenia or leukocytosis (WBC o4 109/l or
412 109/l); or (3) purulent respiratory secre-
tions. Only those patients who presented with
treatment failure caused by noninfectious or
unusual infectious diseases were included. Patients
with severe immune suppression (HIV infection,
solid organ transplantation, severe neutropenia
o1.0 109/l, steroid therapy equivalent to pre-
dnisone in a dose of 420mg/day or any other
immunosuppressive treatment) and those under
age of 14 years were excluded.
All patients received an empiric antimicrobial
therapy suggested by American Thoracic Society
(ATS) guidelines,3 which was usually a combina-
tion of a third-generation cephalosporin with a
macrolide.
Study protocol
Clinical, radiographic and laboratory evaluation
were performed immediately after hospital admis-
sion, before initiating empirical antimicrobial
treatment, and when they fail to improve after
initial antibiotic treatment. The following demo-
graphic data were collected: age, sex, comorbid
illnesses and smoking history. Clinical symptoms
(cough, fever, dyspnea, sputum production, pleuri-
tic pain, hemoptysis, myalgia, weight lossmental
status alteration, asthenia and anorexia, time of
symptoms onset) were recorded on initial evalua-
tion and reassessment. Radiographic data included
extension, location and evolution of pulmonary
infiltrates. Reinvestigation consisted of repeated
chest radiograph and/or CT scan. Routine initial
microbial investigation included sampling of spu-
tum, two sets of blood cultures, and serology for
Legionella pneumophila type 1 and Mycoplasma
pneumoniae. Sputum was processed in the bacter-
iology laboratory for culture only if less than 1%
squamous epithelial cells and more than 25
neutrophils per field were observed.4 Investigation
after treatment failure included new sampling of
sputum and blood cultures and the performance of
additional invasive techniques. These techniques
included: flexible fiberoptic bronchoscopy,
bronchoscopic bronchoalveolar lavage (BAL), trans-
bronchial biopsy (TBB), transthoracic fine needle
aspiration (TFNA) and open lung biopsy (OLB). Bone
marrow aspiration and autopsy also contributed to
diagnosis in some cases.
Definitions
Treatment failure: Assessed 72 h after the begin-
ning of the treatment, included at least one of the
following: persistence of fever (X381C) or hy-
pothermia (o35.51C) plus purulent respiratory
secretions; worsening of the pulmonary infiltrate
by 450%; occurrence of septic shock 5 or multiple
organ dysfunction syndrome (MODS) 6 not present
on the onset.
Unusual infection: Isolation of an uncommon
pathogen (e.g. fungus, tuberculosis) that do not
respond to usual antimicrobial treatment.
Noninfectious disease: Include diseases such as:
pulmonary embolus, congestive heart failure,
obstructive bronchogenic carcinoma, and some
inflammatory lung diseases.
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Mimic of pneumonia: Defined when pulmonary
infiltrates and clinical symptoms of lower respira-
tory tract infection were attributed to a different
diagnosis, other than pneumonia.
Results
During the study period 180 patients were hospita-
lized with suspicion of CAP. Among those 72 (40%)
patients in whom etiology was not defined after
initial microbial investigation, 42 (23.3%) failed to
improve after antimicrobial treatment. Of these,
the failures resulted from inadequate treatment in
22 (12.2%) patients and due to resistant pathogens
in 4 (2.2%). Superinfection with bacterial patho-
gens was not observed. An alternative diagnosis,
other than CAP, was subsequently achieved by
invasive procedures or autopsy in 16 (8.8%). These
16 patients were therefore analyzed.
The characteristics of these patients are de-
scribed in Table 1. The mean age was 35.7 years
(14–88 year), and 9 (56%) were male. None had
previous comorbidity. Three patients had a history
of cigarette smoking but without symptoms of
chronic obstructive pulmonary disease.
Mimics of pneumonia
Half of these 16 patients presented a noninfectious
disease. In two patients pulmonary embolism
with pulmonary infarction was diagnosed and
cryptogenic organizing pneumonia, bronchocentric
granulomatosis, Wegener’s granulomatosis, hyper-
sensitivity pneumonitis, acute leukemia with pul-
monary infiltration and pulmonary metastasis of
gastric carcinoma in one patient each. In the eight
remaining the following unusual infectious diseases
were diagnosed: tuberculosis and cryptococcosis,
both in two patients; actinomycosis, paracoccidioi-
domycosis and histoplasmosis, each in one patient.
Clinical characteristics
The most common clinical symptoms were cough
(100%), fever (100%) and dyspnea (69%). Nine
patients presented with dry cough and seven with
productive cough. Symptoms were much similar
between the two groups and this information
is detailed in Table 2. The mean duration of
symptoms in patients with noninfectious or unusual
infectious diseases were, respectively, 16.2711
and 11.878.7 days.
The radiological patterns most frequently ob-
served were: unilateral parenchymal consolidation
(69%), bilateral interstitial infiltration (12%), bilat-
eral parenchymal consolidation (6%), unilateral
alveolar-interstitial infiltration (6%) and bilateral
alveolar-interstitial infiltration (6%). Three patients
progressed the pulmonary infiltrate and the other
persisted with unaltered chest radiographs. Clinical
and radiological findings are summarized in Table 3.
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Table 1 Patient characteristics.
Case number Age Sex Comorbidity Smoking history (pack-years) Final diagnosis
Non-infectious diseases
1 46 M No 25 Pulmonary embolism
2 42 F No No Pulmonary embolism
3 52 F No 80 COP
4 45 F No No Wegener’s granulomatosis
5 23 F No No Hypersensitivity pneumonitis
6 26 F No No Bronchocentric granulomatosis
7 88 M No No Leukemia
8 31 M No No Neoplastic
Unusual infectious diseases
9 22 M No No Tuberculosis
10 38 F No No Tuberculosis
11 15 F No No Tuberculosis
12 21 M No No Cryptococcosis
13 19 M No No Cryptococcosis
14 44 M No 15 Actinomycosis
15 14 M No No Histoplasmosis
16 45 M No No Paracoccidioidomycosis
Abbreviations: M¼male; F¼ female; COP¼ cryptogenic organizing pneumonia.
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Two of the four patients who required mechanical
ventilation died. Fourteen patients were dis-
charged from hospital with clinical improvement
after specific therapy.
Diagnostic approach
Since the patients were hospitalized with suspicion
of CAP, the initial diagnostic procedures were
directed to bacteria detection. Sputum stained by
Gram, blood cultures and serologies were negative
in all 16 patients.
Further diagnostic approach, by the time of
treatment failure, included the performance of
flexible fiberoptic bronchoscopy with BAL in 14
patients (transbronchial biopsy also performed in
three). BAL fluid culture yielded Mycobacterium
tuberculosis in two patients (Cases 9 and 11); in
one of them the TBB examination revealed the
presence of a granulomatous reaction with caseous
necrosis and mycobacteria were cultured. The
remaining TBB did not provide any further diag-
nostic information. Transthoracic fine needle as-
piration were performed in two patients. The
smears revealed the presence of M. tuberculosis
in 1 case and C. neoformans in the other. Diagnosis
was obtained in all nine patients who were
subjected to open lung biopsy: pulmonary embo-
lism with pulmonary infarction in two patients;
hypersensitivity pneumonitis, bronchocentric gran-
ulomatosis, malignancy, cryptococcosis, actinomy-
cosis, paracoccidioidomycosis and histoplasmosis,
each in one patient. Bone marrow aspiration
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Table 2 Main symptoms presented at hospital admission.
Symptoms Non infectious N (%) Infectious N (%) Total N (%)
Cough 8 (100) 8 (100) 16 (100)
Fever 8 (100) 8 (100) 16 (100)
Dyspnea 7 (87.5) 4 (50) 11 (68.75)
Sputum 5 (62.5) 2 (25) 7 (43.75)
Pleuritic pain 3 (37.5) 5 (62.5) 8 (50)
Hemoptysis 2 (25) 1 (12.5) 3 (18.75)
Myalgia 1 (12.5) 1 (12.5) 2 (12.5)
Weight loss 2 (25) 4 (50) 6 (37.5)
Mental status alteration 1 (12.5) F 1 (6.25)
Asthenia F 2 (25) 2 (12.5)
Anorexia F 2 (25) 2 (12.5)
Table 3 Clinical features.
Case number Temp. WBC count Admission chest radiogrph Radiographic progression MV Symptoms (days)
1 38.5 6360 RLL consolidation ML consolidation No 15
2 38.0 12 000 LUL consolidation Bilateral consolidation No 20
3 39.0 14 000 RUL consolidation No Yes 30
4 39.0 11 000 LUL consolidation No Yes 7
5 39.0 9100 Bilateral infiltrate No No 30
6 39.0 15 000 Lingula consolidation No No 30
7 38.5 2 10 000 Bilateral infiltrate Bilateral consolidation Yes 3
8 38.0 11 000 Bilateral consolidation No Yes 28
9 38.5 9000 LLL consolidation No No 7
10 39.0 16 000 Lingula consolidation No No 15
11 40.0 18 000 RLL consolidation No No 20
12 38.5 8500 LUL consolidation No No 2
13 38.0 10 000 LUL consolidation No No 30
14 38.0 9000 LLL consolidation No No 10
15 38.5 8500 Bilateral inf!ıltrate No No 15
16 38.5 7200 Lingula infiltrate No No 20
Abbreviations: Temp.¼ temperature (1C); WBC¼white blood cell (mm3); RLL¼ right lower lobe; ML¼multilobar; LUL¼ left
upper lobe; RUL¼ right upper lobe; LLL¼ left lower lobe; RML¼ right middle lobe; MV¼mechanical ventilation.
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determined the diagnosis of myelomonocytic leu-
kemia in one patient. Of those two patients who
died, the diagnosis was obtained only in autopsy
(cryptogenic organizing pneumonia and Wegener’s
granulomatosis). Diagnostic approaches are de-
tailed in Table 4.
Discussion
This study described 16 patients who sought
medical attention with signs and symptoms of CAP
who failed to improve after the beginning of
empirical antimicrobial therapy. Alternative diag-
noses were achieved lately, after invasive proce-
dures were performed. Half of the patients had
noninfectious diseases and in the other half unusual
pathogens were isolated. As usually, mimics of
pneumonia were not suspected until treatment
failure.
Patients with CAP usually improve with the
institution of empirical antimicrobial therapy.
However, 10 to 25% of CAP fail to improve despite
of appropriate therapy, therefore being classified
as slowly responding, nonresponding, progressive or
recurrent pneumonia.7 By far, the major cause of
therapeutic failure of CAP is an inadequate selec-
tion of antimicrobials, caused by the presence of an
unexpected or resistant pathogen. Exhaustive
microbial investigation is, thus, mandatory for
patients with treatment failure, in order to
redirect the treatment. However, unusual infec-
tious pathogens and noninfectious diseases should
also be considered in the differential diagnosis,
especially when young and previous healthy pa-
tients with treatment failure are evaluated.8–11
Few studies addressed to unusual infectious and
noninfectious mimics of CAP have been published to
date.9–14 Frequently, unusual infectious and non-
infectious mimics of pneumonia are not routinely
included in the differential diagnosis until several
courses of unsuccessful antimicrobial regimens are
employed. In this series, in two patients who were
diagnosed with pulmonary cryptococcosis by inva-
sive techniques, the cryptococcal antigen test
could be positive; however, it was not performed.
The diagnostic work-up for pulmonary embolism
was not performed in the patients with pulmonary
infarction, since it is not routinely performed
in patients with clinical suspicion of CAP. These
facts are due, in part, to the high incidence
of CAP compared to these diseases, making
their suspicion often belated. The lack of initial
etiologic diagnosis also contributes. In fact, inter-
national guidelines for the management of CAP
recommend the use of empiric therapy,2–15 remain-
ing the etiology unknown in 50–60% of those
patients with CAP despite extensive microbial
investigation.15,16
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TBB TFNA OLB Autopsy BMA
1 Neg Neg Neg Neg F F PE F F
2 F Neg Neg Neg Neg F PE F F
3 Neg Neg Neg Neg F F F COP F
4 Neg Neg Neg Neg Neg F F WG F
5 F Neg Neg Neg F F HP F F
6 Neg Neg Neg Neg F F BcG F F
7 F Neg Neg F F F F F Leukemia
8 Neg Neg Neg Neg F F Malignancy F F
9 Neg Neg Neg TBC F F F F F
10 F Neg Neg Neg F TBC F F F
11 F Neg Neg TBC TBC F F F F
12 F Neg Neg Neg F F Cryptococcosis F F
13 Neg Neg Neg F F Cryptococcosis F F F
14 F Neg Neg Neg F F Actinomycosis F F
15 F Neg Neg Neg F F Histoplasmosis F F
16 F Neg Neg Neg F F PCM F F
Abbreviations: BAL¼bronchoalveolar lavage; TBB¼ transbronchial biopsy; TFNA¼ transthoracic fine needle aspiration;
OLB¼ open lung biopsy; BMA¼bone marrow aspiration; PE¼pulmonary embolism; COP¼ cryptogenic organizing pneumonia;
WG¼Wegener’s granulomatosis; HP¼hypersensitivity pneumonitis; BcG¼bronchocentric granulomatosis; TBC¼ tuberculosis;
PCM¼paracoccidioidomycosis.
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The diagnosis of mimics of CAP may be delayed
for several reasons: (1) low specificity of clinical
diagnosis (fever, cough, respiratory secretion and
pulmonary infiltrates); (2) lack of initial etiological
confirmation due to the lack of rapid diagnostic
methods; (3) delayed broad etiological investiga-
tion; (4) absence of individualized analysis of the
cases; (5) difficulty in determining the right
moment for invasive diagnostic methods; (6) cost–
benefit assessment; and (7) oversight of mimics of
CAP on differential diagnosis at admission.
Discrimination between infectious and noninfec-
tious diseases that mimic pneumonia is laborious.
Symptoms and radiological findings are of little
value for this differentiation.17,18 Routine labora-
tory tests (serum electrolytes, hepatic enzymes
and renal function) also may not help, since they
can be abnormal in some patients with CAP. On the
other hand, some findings in urinalysis or eosino-
philia, for example, are not expected in CAP, but
can be observed in some noninfectious diseases like
drug-induced pulmonary disease, chronic eosino-
philic pneumonia, allergic bronchopulmonary as-
pergillosis, collagen vascular disease and
granulomatous vasculitis. A detailed epidemiologi-
cal history (travels, occupational exposure, drug
use) may lead to the diagnosis of an unusual cause
of CAP (tuberculosis, fungi, psittacosis) and help to
exclude immune-mediated diseases (hypersensitiv-
ity pneumonitis or drug-induced pulmonary dis-
ease). In addition, the spectrum of diseases among
patients with nonresolving infiltrates depends at
least in part from regional characteristics (e.g.
tuberculosis prevalence, endemic mycosis). The
presence of multi-organ involvement, underlying
disease (e.g., collagen vascular disease), extrapul-
monary involvement, prolonged clinical course and
recurrent pneumonia in patients without structural
lung disease or immunodeficiency should highlight
the possible presence of noninfectious diseases,
while the history of medical comorbidity (smoking,
alcoholism, underlying cardiopulmonary disease)
suggests infectious diseases.7
Specific diagnosis of mimics of pneumonia is
usually achieved after the performance of serologic
exams, invasive procedures and histological stu-
dies.19–21 In our study the subsequent diagnoses
were established by invasive procedures (87.5%) or
in autopsy (12.5%). No complications were reported
after the performance of invasive procedures (open
lung biopsy in nine cases, flexible fiberoptic
bronchoscopy in two, transthoracic fine needle
aspiration in two).
In conclusion, unusual infectious and noninfec-
tious diseases should always suspected and in-
cluded in the differential diagnosis of patients with
presumptive diagnosis of pneumonia but who
present with treatment failure, specially those
young and previous healthy patients. The first step
toward those diagnostics is to constantly be aware
of their possible presence.
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